FdaApplication
ANDA 210319
Identifiers
- fda_app_no: ANDA210319
Properties
| Property | Value |
|---|---|
| applicant_name | MEDLEY PHARMACEUTICALS LTD |
| application_type | ANDA |
| approval_date | 2020-08-31 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| MEMANTINE HYDROCHLORIDE | MEMANTINE HYDROCHLORIDE | 2MG/ML | SOLUTION;ORAL |
1 product